The effect of Roux-en-Y bariatric surgery on early and late cardiovascular risk markers in patients with obesity

ISRCTN ISRCTN21400062
DOI https://doi.org/10.1186/ISRCTN21400062
Secondary identifying numbers R0782
Submission date
27/04/2009
Registration date
13/05/2009
Last edited
17/12/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Stephen Atkin
Scientific

HS Brocklehurst Building
Hull Royal Infirmary
Anlaby Road
Hull
HU3 2RW
United Kingdom

Study information

Study designObservational prospective longitudinal study
Primary study designObservational
Secondary study designOther
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleThe effect of Roux-en-Y bariatric surgery on early and late cardiovascular risk markers in patients with obesity: an observational prospective study
Study acronymBariatric surgery - CVR
Study objectivesTo demonstrate the effects of Roux-en-Y bariatric surgery on both early and late manifestations of cardiovascular disease.
Ethics approval(s)Hull and East Riding Local Research Ethics Committee, approved on 12/03/2009 (ref: 09/H1304/3).
Health condition(s) or problem(s) studiedObesity
InterventionPatients will be seen before surgery and then at 3 monthly intervals for 12 months after surgery. At each visit fasting bloods will be taken to determine insulin resistance along with fibrin structure and function. Endothelial function will be examined using Endo-PAT2000®.
Intervention typeOther
Primary outcome measureTo show that Roux-en-Y surgery significantly improves endothelial function.
Secondary outcome measuresTo illustrate that bariatric surgery improves fibrin clot structure and function.
Overall study start date14/04/2009
Completion date30/09/2010

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants40
Key inclusion criteria1. Both males and females, over age of 16 years
2. Body Mass Index greater than 40 kg/m^2, or greater than 35 kg/m^2 with comorbidity
3. To have Roux-en-Y bariatric surgery
4. Able to give informed consent
5. Consent to inform their GP's regarding their participation in the study
6. No changes to medication in last 3 months
7. Smokers can be included
Key exclusion criteriaPatients not wishing disclosure to their GP's.
Date of first enrolment14/04/2009
Date of final enrolment30/09/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

HS Brocklehurst Building
Hull
HU3 2RW
United Kingdom

Sponsor information

Hull and East Yorkshire Hospitals NHS Trust (UK)
Hospital/treatment centre

Daisy Building
Castle Hill Hospital
Cottingham
HU16 5JQ
England
United Kingdom

Website http://www.hey.nhs.uk
ROR logo "ROR" https://ror.org/01b11x021

Funders

Funder type

University/education

Diabetes Endowment Fund, University of Hull (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/03/2014 Yes No